Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 271

1.

A national survey of primary care physicians' methods for screening for fecal occult blood.

Nadel MR, Shapiro JA, Klabunde CN, Seeff LC, Uhler R, Smith RA, Ransohoff DF.

Ann Intern Med. 2005 Jan 18;142(2):86-94.

PMID:
15657156
2.

Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations.

Nadel MR, Berkowitz Z, Klabunde CN, Smith RA, Coughlin SS, White MC.

J Gen Intern Med. 2010 Aug;25(8):833-9. doi: 10.1007/s11606-010-1328-7. Epub 2010 Apr 10.

3.

A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.

Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, Cordes JE, Engelhard D.

J Natl Cancer Inst. 2004 May 19;96(10):770-80.

PMID:
15150305
4.

Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.

Baig N, Myers RE, Turner BJ, Grana J, Rothermel T, Schlackman N, Weinberg DS.

Am J Gastroenterol. 2003 Sep;98(9):2078-81.

PMID:
14499791
5.

Validation of self-reported history of colorectal cancer screening.

Khoja S, McGregor SE, Hilsden RJ.

Can Fam Physician. 2007 Jul;53(7):1192-7.

6.

A national survey of primary care physicians' colorectal cancer screening recommendations and practices.

Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, Vernon SW.

Prev Med. 2003 Mar;36(3):352-62.

PMID:
12634026
7.

Inappropriate use of the faecal occult blood test outside of the National Health Service colorectal cancer screening programme.

Peacock O, Watts ES, Hanna N, Kerr K, Goddard AF, Lund JN.

Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1270-5.

PMID:
22872076
8.

Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007.

Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW.

Am J Prev Med. 2009 Jul;37(1):8-16. doi: 10.1016/j.amepre.2009.03.008. Epub 2009 May 13.

9.

Physicians' recommendations for colon cancer screening in women. Too much of a good thing?

Richards C, Klabunde C, O'Malley M.

Am J Prev Med. 1998 Oct;15(3):246-9.

PMID:
9791644
10.

Colorectal cancer screening by primary care physicians in two medical care organizations.

Hawley ST, Levin B, Vernon SW.

Cancer Detect Prev. 2001;25(3):309-18.

PMID:
11425273
11.

Summaries for patients. Use of colorectal cancer screening by doctors in practice.

[No authors listed]

Ann Intern Med. 2005 Jan 18;142(2):I26. No abstract available.

PMID:
15657151
12.

Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007.

Yabroff KR, Saraiya M, Meissner HI, Haggstrom DA, Wideroff L, Yuan G, Berkowitz Z, Davis WW, Benard VB, Coughlin SS.

Ann Intern Med. 2009 Nov 3;151(9):602-11. doi: 10.7326/0003-4819-151-9-200911030-00005.

PMID:
19884621
13.

Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening.

Myers RE, Hyslop T, Gerrity M, Schlackman N, Hanchak N, Grana J, Turner BJ, Weinberg D, Hauck WW.

Cancer Epidemiol Biomarkers Prev. 1999 Jul;8(7):587-93.

14.

Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test.

Turner B, Myers RE, Hyslop T, Hauck WW, Weinberg D, Brigham T, Grana J, Rothermel T, Schlackman N.

J Gen Intern Med. 2003 May;18(5):357-63.

15.

Screening for colorectal cancer on the front line.

Lemon SC, Zapka JG, Estabrook B, Erban S, Luckmann R.

Am J Gastroenterol. 2003 Apr;98(4):915-23.

PMID:
12738477
16.

Diagnostic testing following fecal occult blood screening in the elderly.

Lurie JD, Welch HG.

J Natl Cancer Inst. 1999 Oct 6;91(19):1641-6.

PMID:
10511591
17.

Increase in screening for colorectal cancer in older Americans: results from a national survey.

Chen X, White MC, Peipins LA, Seeff LC.

J Am Geriatr Soc. 2008 Aug;56(8):1511-6. doi: 10.1111/j.1532-5415.2008.01796.x. Epub 2008 Jul 24.

PMID:
18662217
18.

Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines.

Fisher JA, Fikry C, Troxel AB.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):108-13. Review.

19.

Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice.

Collins JF, Lieberman DA, Durbin TE, Weiss DG; Veterans Affairs Cooperative Study #380 Group..

Ann Intern Med. 2005 Jan 18;142(2):81-5.

PMID:
15657155
20.

What is the role of family in promoting faecal occult blood test screening? Exploring physician, average-risk individual, and family perceptions.

Lobchuk MM, Bapuji SB, McClement SE, Sisler JJ, Katz A, Martens P, Turner D, Clouston K.

Cancer Epidemiol. 2012 Jun;36(3):e190-9. doi: 10.1016/j.canep.2012.01.002. Epub 2012 Feb 5.

PMID:
22310235

Supplemental Content

Support Center